NCT00006089 · Interventional trial
Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Overall registry status Completed
Phase 2
Conditions ERBB2 Gene Amplification, Endometrial Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7
Delaware Valley sites
- Gynecologic Oncology Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory